Petros Pharmaceuticals Analysis

Petros Pink Sheet Analysis Notes

The company has price-to-book ratio of 0.45. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Petros Pharmaceuticals recorded a loss per share of 63.15. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 1st of May 2025. Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on mens health therapeutics. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.The quote for Petros Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Petros Pharmaceuticals contact the company at 973 242 0005 or learn more at https://petrospharma.com.

Petros Pharmaceuticals Investment Alerts

Petros Pharmaceuticals Upcoming and Recent Events

Petros Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 265.45 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Petros Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Petros Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Petros Profitablity

The company has Profit Margin (PM) of (2.8) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.41) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.41.

Petros Pharmaceuticals Insider Trading Activities

Petros Pharmaceuticals Outstanding Bonds

Petros Pharmaceuticals Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Petros Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Petros shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Petros Pharmaceuticals. By using and applying Petros Pink Sheet analysis, traders can create a robust methodology for identifying Petros entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

If you are still planning to invest in Petros Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Petros Pharmaceuticals' history and understand the potential risks before investing.